CONMED
CNMD
#3878
Rank
$2.23 B
Marketcap
$72.64
Share price
2.19%
Change (1 day)
-36.85%
Change (1 year)
Categories

P/E ratio for CONMED (CNMD)

P/E ratio as of April 2024 (TTM): 37.4

According to CONMED's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 37.4105. At the end of 2022 the company had a P/E ratio of -32.1.

P/E ratio history for CONMED from 2001 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-32.1-148.48%
202166.2-80.48%
2020339209.56%
2019110149.33%
201844.071.68%
201725.6-69.85%
201684.9112.11%
201540.05.1%
201438.116.55%
201332.767.26%
201219.5-96.95%
20116422473.8%
201024.9-55.16%
200955.6220.56%
200817.38.85%
200715.9-131.71%
2006-50.3-333.67%
200521.5-14.48%
200425.246.89%
200317.110.13%
200215.5-20.81%
200119.6

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
10.3-72.34%๐Ÿ‡บ๐Ÿ‡ธ USA
29.1-22.18%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
82.2 119.78%๐Ÿ‡บ๐Ÿ‡ธ USA
48.1 28.53%๐Ÿ‡บ๐Ÿ‡ธ USA
24.1-35.54%๐Ÿ‡บ๐Ÿ‡ธ USA
25.9-30.70%๐Ÿ‡บ๐Ÿ‡ธ USA
21.4-42.80%๐Ÿ‡ฌ๐Ÿ‡ง UK

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.